Canada markets closed

AbbVie Inc. (4AB.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
150.00-1.48 (-0.98%)
At close: 12:51PM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 270.29B
Enterprise Value 313.70B
Trailing P/E 48.32
Forward P/E 14.53
PEG Ratio (5 yr expected) 0.43
Price/Sales (ttm)5.29
Price/Book (mrq)27.75
Enterprise Value/Revenue 5.77
Enterprise Value/EBITDA 32.49

Trading Information

Stock Price History

Beta (5Y Monthly) 0.56
52-Week Change 312.02%
S&P500 52-Week Change 322.38%
52 Week High 3168.80
52 Week Low 3119.00
50-Day Moving Average 3160.51
200-Day Moving Average 3145.99

Share Statistics

Avg Vol (3 month) 3215
Avg Vol (10 day) 392
Shares Outstanding 51.77B
Implied Shares Outstanding 61.8B
Float 81.76B
% Held by Insiders 10.11%
% Held by Institutions 171.78%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 45.84
Forward Annual Dividend Yield 43.85%
Trailing Annual Dividend Rate 36.06
Trailing Annual Dividend Yield 34.00%
5 Year Average Dividend Yield 44.41
Payout Ratio 4178.27%
Dividend Date 3N/A
Ex-Dividend Date 4Apr 12, 2024
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 11.02%
Operating Margin (ttm)28.02%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)54.4B
Revenue Per Share (ttm)30.78
Quarterly Revenue Growth (yoy)0.70%
Gross Profit (ttm)N/A
EBITDA 26.17B
Net Income Avi to Common (ttm)5.95B
Diluted EPS (ttm)3.11
Quarterly Earnings Growth (yoy)472.80%

Balance Sheet

Total Cash (mrq)12.82B
Total Cash Per Share (mrq)7.26
Total Debt (mrq)60.58B
Total Debt/Equity (mrq)582.66%
Current Ratio (mrq)N/A
Book Value Per Share (mrq)5.87

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A